Download PDF
Nervenheilkunde 2007; 26(10): 923-927
DOI: 10.1055/s-0038-1626946
Neuroethik & Neurophilosophie
Schattauer GmbH

Neuromodulatorische Interventionen zur Therapie psychiatrischer Erkrankungen

Empirische Perspektiven und ethische Implikationen
T. Schläpfer
Further Information

Publication History

Publication Date:
19 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Kessler R, McGonagle K, Zhao S, Nelson C, Hughes M, Eshleman S, Wittchen H, Kendler K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives Of General Psychiatry 1994; 51 (01) 8-19.
    CrossrefPubMedGoogle Scholar
  • 2 Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. The Lancet 1997; 349: 1436-1442.
    CrossrefPubMedGoogle Scholar
  • 3 Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001; 179: 498-502.
    CrossrefPubMedGoogle Scholar
  • 4 Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155 (01) 4-11.
    CrossrefPubMedGoogle Scholar
  • 5 Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med 1999; 61 (01) 6-17.
    CrossrefPubMedGoogle Scholar
  • 6 Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311 (5762): 864-868.
    CrossrefPubMedGoogle Scholar
  • 7 Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006; 07 (02) 137-151.
    CrossrefPubMedGoogle Scholar
  • 8 Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, Yacoubi ME, Vaugeois JM, Nomikos GG, Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311 (5757): 77-80.
    CrossrefPubMedGoogle Scholar
  • 9 Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2001; 02 (05) 343-351.
    CrossrefPubMedGoogle Scholar
  • 10 Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T. Time to recovery, chronicity, and levels of psychopathology in major depression.A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49 (10) 809-816.
    CrossrefPubMedGoogle Scholar
  • 11 Nemeroff C. Augmentation strategies in patients with refractory depression. Depress Anxiety 1996; 04: 169-181.
    CrossrefPubMedGoogle Scholar
  • 12 Mann JJ. The medical management of depression. N Engl J Med 2005; 353 (17) 1819-1834.
    CrossrefPubMedGoogle Scholar
  • 13 Mayberg H. Modulating dysfunctional limbiccortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003; 65: 193-207.
    CrossrefPubMedGoogle Scholar
  • 14 Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997; 09 (03) 471-481.
    CrossrefPubMedGoogle Scholar
  • 15 Mayberg HS. Positron emission tomography imaging in depression:a neural systems perspective. Neuroimaging Clin NAm 2003; 13 (04) 805-815.
    Google Scholar
  • 16 Mayberg HS. Modulating dysfunctional limbiccortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65: 193-207.
    CrossrefPubMedGoogle Scholar
  • 17 Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126: 413-431.
    PubMedGoogle Scholar
  • 18 Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology 2001; 11 (02) 240-249.
    CrossrefPubMedGoogle Scholar
  • 19 Schlaepfer TE, Lieb K. Deep Brain Stimulation for Treatment Refractory Depression. Lancet 2005; 366 (9495): 1420-1422.
    CrossrefPubMedGoogle Scholar
  • 20 Deuschl G, Bain P. Deep brain stimulation for tremor: patient selection and evaluation. Mov Disord 2002; 17 Suppl 3: S102-111.
    PubMedGoogle Scholar
  • 21 Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355 (09) 896-908.
    CrossrefPubMedGoogle Scholar
  • 22 Nuttin B, Gybels J, Cosyns P, Gabriels L, Meyerson B, Andréewitch S, Rasmussen S, Greenberg B, Friehs G, Rezai AR, Montgomery E, Malone D, Fins JJ. Deep Brain Stimulation for Psychiatric Disorders. Neurosurgery 2002; 51 (02) 519.
    CrossrefPubMedGoogle Scholar
  • 23 Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006; 31 (11) 2394.
    CrossrefGoogle Scholar
  • 24 Mayberg H, Lozano A, Voon V, McNeely H, Seminowicz D, Hamani C, Schwalb J, Kennedy S. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45 (05) 651-660.
    CrossrefPubMedGoogle Scholar
  • 25 Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AJ, Kreft M, Lenartz D, Sturm V. Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression. Neuropsychopharmacology. 2007 doi:10.1038/sj.npp.1301408.
    PubMedGoogle Scholar
  • 26 Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, Kopell B. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001; 77 (1–4): 73-78.
    CrossrefPubMedGoogle Scholar
  • 27 Fins JJ, Rezai AR, Greenberg BD. Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery 2006; 59 (04) 713-716.
    CrossrefPubMedGoogle Scholar
  • 28 Farah MJ. Emerging ethical issues in neuroscience. Nat Neurosci 2002; 05 (11) 1123-1129.
    CrossrefPubMedGoogle Scholar
  • 29 Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR. Neurocognitive enhancement: what can we do and what should we do?. Nat Rev Neurosci 2004; 05 (05) 421-425.
    CrossrefPubMedGoogle Scholar